Hadronic Production of psi(2S) Cross section and Polarization

The hadronic production cross section and the polarization of {psi}(2S) meson are measured by using the data from p{bar p} collisions at {radical}s = 1.96 TeV collected by the Collider Detector at Fermilab. The datasets used correspond to integrated luminosity of 1.1 fb{sup -1} and 800 pb{sup -1}, respectively. The decay {psi}(2S) {yields} {mu}{sup +}{mu}{sup -} is used to reconstruct {psi}(2S) mesons in the rapidity range |y({psi}(2S))| < 0.6. The coverage of the p{sub T} range is 2.0 GeV/c {le} p{sub T} ({psi}(2S)) < 30 GeV/c for the cross section analysis and pT {ge} 5 GeV/c for the polarization analysis. For events with p{sub T} ({psi}(2S)) > 2 GeV/c the integrated inclusive cross section multiplied by the branching ratio for dimuon decay is 3.17 {+-} 0.04 {+-} 0.28 nb . This result agrees with the CDF Run I measurement considering the increased center-of-mass energy from 1.8 TeV to 1.96 TeV. The polarization of the promptly produced {psi}(2S) mesons is found to be increasingly longitudinal as p{sub T} increases from 5 GeV/c to 30 GeV/c. The result is compared to contemporary theory models

Normal lung sparing Tomotherapy technique in stage III lung cancer

Abstract Purpose Radiation pneumonitis (RP) has been a challenging obstacle in treating stage III lung cancer patients. Beam angle optimization (BAO) technique for Tomotherapy was developed to reduce the normal lung dose for stage III non-small cell lung cancer (NSCLC). Comparative analyses on plan quality by 3 different Intensity-modulated radiation therapy (IMRT) methods with BAO were done. Materials and methods Ten consecutive stage IIIB NSCLC patients receiving linac-based static IMRT (L-IMRT) with total 66 Gy in 33 fractions to the PTV were selected. Two additional Tomotherapy-based IMRT plans (helical beam (TH-IMRT) and static beam (TD-IMRT)) were generated on each patient. To reduce the normal lung dose, Beam angles were optimized by using complete and directional block functions in Tomotherapy based on knowledge based statistical analysis. Plan quality was compared with target coverage, normal organ sparing capability, and normal tissue complication probability (NTCP). Actual beam delivery times and risk of RP related with planning target volume (PTV) were also evaluated. Results The best PTV coverage measured by conformity index and homogeneity index was achievable by TH-IMRT (0.82 and 1.06), followed by TD-IMRT (0.81 and 1.07) and L-IMRT (0.75 and 1.08). Mean lung dose was the lowest in TH-IMRT plan followed by TD-IMRT and L-IMRT, all of which were ≤20 Gy. TH-IMRT plan could significantly lower the lung volumes receiving low to medium dose levels: V5~30 when compared to L-IMRT plan; and V5~20 when compared to TD-IMRT plan, respectively. TD-IMRT plan was significantly better than L-IMRT with respects to V20 and V30 and there was no significant difference with respect to V40 among three plans. The NTCP of the lung was the lowest in TH-IMRT plan, followed by TD-IMRT and L-IMRT (6.42% vs. 6.53% vs. 8.11%). Beam delivery time was the shortest in TD-IMRT plan followed by L-IMRT. As PTV length increased, NTCP and Mean lung dose proportionally increased significantly in all three plans. Conclusion Advantageous profiles by TH-IMRT could be achieved by BAO by complete and directional block functions. Current observation could help radiation oncologists to make wise selection of IMRT method for stage IIIB NSCLC

Gold nanoparticles as a potent radiosensitizer in neutron therapy.

The purpose of this study was to investigate the potential of gold nanoparticles as radiosensitizer for use in neutron therapy against hepatocellular carcinoma. The hepatocellular carcinoma cells lines Huh7 and HepG2 were irradiated with γ and neutron radiation in the presence or absence of gold nanoparticles. Effects were evaluated by transmission electron microscopy, cell survival, cell cycle, DNA damage, migration, and invasiveness. Gold nanoparticles significantly enhanced the radiosensitivity of Huh7 and HepG2 cells to γ-rays by 1.41- and 1.16-fold, respectively, and by 1.80- and 1.35-fold to neutron radiation, which has high linear energy transfer. Accordingly, exposure to neutron radiation in the presence of gold nanoparticles induced cell cycle arrest, DNA damage, and cell death to a significantly higher extent, and suppressed cell migration and invasiveness more robustly. These effects are presumably due to the ability of gold nanoparticles to amplify the effective dose from neutron radiation more efficiently. The data suggest that gold nanoparticles may be clinically useful in combination therapy against hepatocellular carcinoma by enhancing the toxicity of radiation with high linear energy transfer